Infect Chemother.  2015 Mar;47(1):41-48. 10.3947/ic.2015.47.1.41.

Influenza and Pneumococcal Vaccine Coverage Rates among Patients Admitted to a Teaching Hospital in South Korea

Affiliations
  • 1Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. heejinmd@korea.ac.kr

Abstract

BACKGROUND
Influenza and pneumococcal vaccinations can reduce morbidity and mortality especially in the elderly and patients with chronic medical disease. The purpose of this study was to estimate vaccination coverage of these populations in a hospital setting.
MATERIALS AND METHODS
We conducted a cross-sectional, descriptive study involving adult patients admitted to a 1,000-bed teaching hospital on April 15, 2013. We ascertained the information on whether the patient had received influenza vaccination within a year prior to admission or pneumococcal vaccination by interviewing each patient.
RESULTS
A total of 491 eligible patients aged > or =50 years or with chronic medical illnesses were analyzed. The overall vaccination rate for influenza was 57.2%, and that of pneumococcus was 17.6% among the vaccine-eligible subjects. Influenza/pneumococcal vaccination rates of patients by disease were 62.8%/17.2% for diabetes, 53.3%/15.6% for malignancy, 67.6%/23.5% for chronic pulmonary disease, 66.7%/15.3% for chronic cardiovascular disease, 68.7%/26.9% for chronic renal disease, and 51.2%/18.6% for chronic hepatic disease. Young adult patients with chronic medical conditions were consistently less likely to receive influenza and pneumococcal vaccines irrespective of the underlying disease.
CONCLUSION
The influenza and pneumococcal vaccine coverage rates among hospitalized patients were low in South Korea. This was especially the case for young adult patients with chronic medical illnesses.

Keyword

Influenza; Streptococcus pneumoniae; Vaccination; Hospitalization; Health survey

MeSH Terms

Adult
Aged
Cardiovascular Diseases
Health Surveys
Hospitalization
Hospitals, Teaching*
Humans
Influenza, Human*
Korea
Lung Diseases
Mortality
Pneumococcal Vaccines
Renal Insufficiency, Chronic
Streptococcus pneumoniae
Vaccination
Young Adult
Pneumococcal Vaccines

Figure

  • Figure 1 Screening, exclusion and assignment of the study population. KUGH, Korea University Guro Hospital. aNumbers in parentheses refer to the number of patients who meet the condition. bUnderlying medical condition denotes a chronic medical disease or immunocompromising conditions.

  • Figure 2 Influenza and pneumococcal vaccination rates by age group and chronic medical disease. (A) Influenza vaccine. (B) Pneumococcal vaccine.


Cited by  1 articles

Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines
Jung Yeon Heo, Joon Young Song
Infect Chemother. 2018;50(4):287-300.    doi: 10.3947/ic.2018.50.4.287.


Reference

1. Yoo KH, Yoo CG, Kim SK, Jung JY, Lee MG, Uh ST, Shim TS, Jeon K, Shim JJ, Lee HB, Chung CR, Kang KW, Jung KS. Economic burden and epidemiology of pneumonia in Korean adults aged over 50 years. J Korean Med Sci. 2013; 28:888–895.
Article
2. Song JY, Choi JY, Lee JS, Bae IG, Kim YK, Sohn JW, Jo YM, Choi WS, Lee J, Park KH, Kim WJ, Cheong HJ. Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study. BMC Infect Dis. 2013; 13:202.
Article
3. Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL. AGEDD Adult Pneumococcal Burden Study Team. Andreo F, Beovic B, Blanco S, Boersma WG, Boulware DR, Butler JC, Carratalà J, Chang FY, Charles PG, Diaz AA, Domínguez J, Ehara N, Endeman H, Falcó V, Falguera M, Fukushima K, Garcia-Vidal C, Genne D, Guchev IA, Gutierrez F, Hernes SS, Hoepelman AI, Hohenthal U, Johansson N, Kolek V, Kozlov RS, Lauderdale TL, Mareković I, Masiá M, Matta MA, Miró Ò, Murdoch DR, Nuermberger E, Paolini R, Perelló R, Snijders D, Plečko V, Sordé R, Strålin K, van der Eerden MM, Vila-Corcoles A, Watt JP. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One. 2013; 8:e60273.
Article
4. Statistics Korea. Causes of Death Statistics in 2013. Accessed 25 February 2015. Available at: http://kostat.go.kr/portal/english/news/1/25/4/index.board?bmode=read&bSeq=&aSeq=330671&pageNo=1&rowNum=10&navCount=10&currPg=&sTarget=title&sTxt=.
5. Health Insurance Review & Assessment Service. National Health Insurance Statistical Yearbook. Seoul, South Korea: National Health Insurance Service;2012.
6. Kyaw MH, Rose CE Jr, Fry AM, Singleton JA, Moore Z, Zell ER, Whitney CG. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005; 192:377–386.
Article
7. Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, Green K, McGeer A. Toronto Invasive Bacterial Diseases Network. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant. 2008; 41:743–747.
Article
8. Dower J, Donald M, Begum N, Vlack S, Ozolins I. Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia. Vaccine. 2011; 29:3031–3037.
Article
9. Nichol KL. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults. Am J Med. 1998; 105:385–392.
Article
10. Andrews RM, Skull SA, Byrnes GB, Campbell DA, Turner JL, McIntyre PB, Kelly HA. Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria. Commun Dis Intell Q Rep. 2005; 29:283–288.
11. Lim J, Eom CS, Kim KH, Kim S, Cho B. Coverage of influenza vaccination among elderly in South Korea: a population based cross sectional analysis of the season 2004-2005. J Korean Geriatr Soc. 2009; 13:215–221.
Article
12. Kim MJ. Disease burden of pneumococcal infection and serotypes of Streptococcus pneumoniae in Korean adults. Korea Center for Disease Control and Prevention;2008. Accessed 16 March 2015. Available at: http://cdc.go.kr/CDC/info/CdcKrInfo0201.jsp?menuIds=HOME001-MNU1155-MNU1083-MNU1375-MNU0025&cid=1326.
13. Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system. Accessed Date 2013. Accessed 16 March 2015. Available at: http://apps.nccd.cdc.gov/BRFSS/.
14. Song JY, Cheong HJ, Heo JY, Noh JY, Seo YB, Kim IS, Choi WS, Kim WJ. Outpatient-based pneumococcal vaccine campaign and survey of perceptions about pneumococcal vaccination in patients and doctors. Yonsei Med J. 2013; 54:469–475.
Article
15. Kee SY, Cheong HJ, Chun BC, Kim WJ. Influenza vaccination coverage rate and factors associated with vaccination in people with chronic disease. Infect Chemother. 2011; 43:406–411.
Article
16. Lim J, Eom CS, Kim S, Ke S, Cho B. Pneumococcal vaccination rate among ederly in South Korea. J Korean Geriatr Soc. 2010; 14:18–24.
Article
17. Kee SY, Lee JS, Cheong HJ, Chun BC, Song JY, Choi WS, Jo YM, Seo YB, Kim WJ. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect. 2007; 55:273–281.
Article
18. Ministry of Health and Welfare. Prevention and Control of Seasonal Influenza, 2014. Cheongju, Republic of Korea: Accessed 16 March 2015. Available at: https://nip.cdc.go.kr/irgd/index.html.
19. Korea Society of Infectious Diseases. Adult immunization schedule. Accessed 25 February 2015. Available at: http://www.ksid.or.kr/.
20. Kee SY, Cheong HJ, Chun BC, Kim WJ. Influenza vaccination coverage rate and factors associated with vaccination in people with chronic disease. Infect Chemother. 2011; 43:406–411.
Article
21. Arencibia Jiménez M, Navarro Gracia JF, Delgado de Los Reyes JA, Pérez Torregrosa G, López Parra D, López García P. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention? Arch Bronconeumol. 2014; 50:93–98.
Article
22. Fedson DS, Baldwin JA. Previous hospital care as a risk factor for pneumonia. Implications for immunization with pneumococcal vaccine. JAMA. 1982; 248:1989–1995.
Article
23. Fedson DS, Chiarello LA. Previous hospital care and pneumococcal bacteremia. Importance for pneumococcal immunization. Arch Intern Med. 1983; 143:885–889.
Article
24. Nichol KL, Mac Donald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med. 1996; 11:673–677.
Article
25. Korea Centers for Disease Control and Prevention (KCDC). Elderly pneumococcal vaccination status in 2012, Korea. Cheongju, Korea: KCDC;2012.
26. Kwon YH, Kim ES. Planning and implementation of elderly immunization program against invasive pneumococcal disease in Korea. Public Health Wkly Rep. 2013; 6:649–653.
27. McKibben LJ, Stange PV, Sneller VP, Strikas RA, Rodewald LE. Advisory Committee on Immunization Practices. Use of standing orders programs to increase adult vaccination rates. MMWR Recomm Rep. 2000; 49:15–16.
28. Thomas CM, Loewen A, Coffin C, Campbell NR. Improving rates of pneumococcal vaccination on discharge from a tertiary center medical teaching unit: a prospective intervention. BMC Public Health. 2005; 5:110.
Article
29. Williams WW, Lu PJ, O'Halloran A, Bridges CB, Pilishvili T, Hales CM, Markowitz LE. Centers for Disease Control and Prevention (CDC). Noninfluenza vaccination coverage among adults - United States, 2012. MMWR Morb Mortal Wkly Rep. 2014; 63:95–102.
30. World Health Organization. Principles and considerations for adding a vaccine to a national immunization programme. Geneva, Switzerland: WHO;2014.
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr